Updated Jul 16, 2026
Waldman Reid Alexander has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Reid Alexander Waldman is the Chief Executive Officer of Veradermics, Inc. He has been involved in the company since its inception and has played a significant role in its development and strategic direction. His background includes experience in the biotechnology sector, focusing on innovative solutions in dermatology.
| Role | Insider |
|---|---|
| Notability | 10/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-02-06 | MANE | Veradermics, Inc | J — Other acquisition / disposition | 1.4K | — |
Reid Alexander Waldman is the Chief Executive Officer of Veradermics, Inc. He has been involved in the company since its inception and has played a significant role in its development and strategic direction. His background includes experience in the biotechnology sector, focusing on innovative solutions in dermatology.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Waldman Reid Alexander profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.